&lt;p&gt;Anticancer activity of 1, 25-(OH)&lt;sub&gt;2&lt;/sub&gt;D&lt;sub&gt;3&lt;/sub&gt; against human breast cancer cell lines by targeting Ras/MEK/ERK pathway&lt;/p&gt;

Wei Zheng; Daoxing Gong; Bofeng Duan; Lin Cao; Linna Ouyang; Shan Chen; Qian Zhang; Yi Xie; Qing Fan; Wei Zhou; Wei Peng

doi:10.2147/ott.s190432

Anticancer activity of 1, 25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway

Wei Zheng(Shenzhen Third People’s Hospital), Daoxing Gong(University of South China), Bofeng Duan(Shenzhen Third People’s Hospital), Lin Cao(Sun Yat-sen University), Linna Ouyang(Shenzhen Third People’s Hospital), Shan Chen(Third Hospital of Changsha), Qian Zhang(Changzhou No.2 People's Hospital), Yi Xie(Fudan University), Qing Fan(Chongqing University), Wei Zhou(Broad Institute), Wei Peng(Shanxi Medical University)

OncoTargets and Therapy

January 1, 2019

10.2147/ott.s190432

Cited by 31